Atlas Trials

Respiratory Syncytial Viruses

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Respiratory Syncytial Viruses

RecordFirmDate
A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older (NCT04908683)Janssen Vaccines & Prevention B.V.2021-07-21
A Two-Part Infant Study for Early Diagnosis of Respiratory Syncytial Virus (RSV) and Evaluation of JNJ-53718678 in RSV Acute Respiratory Tract Disease (NCT04068792)Janssen Research & Development, LLC2019-10-10
A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older (NCT03982199)Janssen Vaccines & Prevention B.V.2019-08-01
A Study to Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of Age (NCT03303625)Janssen Vaccines & Prevention B.V.2017-11-29
A Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Infants and Children Aged 28 Days to 36 Months Infected With Respiratory Syncytial Virus (NCT03333317)Janssen Research & Development, LLC2017-11-24
Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Aluminum Phosphate or Matrix-M1™ Adjuvants In Clinically-Stable Older Adults (NCT03026348)Novavax2017-01-01
Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine Regimens in Adult Participants Hospitalized With Respiratory Syncytial Virus (NCT02935673)Janssen Research & Development, LLC2016-10-25
A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers (NCT02561871)Crucell Holland BV2015-09-01
The Respiratory Protection Effectiveness Clinical Trial (NCT01249625)Johns Hopkins University2010-12-01
Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian Children (NCT00585481)Abbott2008-01-01
TGV:Use of the Quick Diagnostic Test of the Influenza and the Infection With RSV by the Paediatric Emergency Unit (NCT00263900)University Hospital, Rouen2005-12-01

Track Respiratory Syncytial Viruses automatically

Every clearance here is in the API, with alerts when new ones post.